<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

News and Stories

Research

Research    Press Releases

Celebrated Ancient Egyptian Woman Physician Likely Never Existed, Says Researcher

For decades, an ancient Egyptian known as Merit Ptah has been celebrated as the first female physician and a role model for women entering medicine. Yet a researcher from the University of Colorado Anschutz Medical Campus now says she never existed and is an example of how misconceptions can spread.


Author David Kelly | Publish Date December 18, 2019
Full Story

Research

CU Anschutz Launches Comprehensive Directory of Research Studies

Here at the Anschutz Medical Campus, we are in the business of answering important research questions in order to improve human health. One of the ways our physicians and scientists do this is through research studies that involve human participants who volunteer to make the studies possible.


Author Guest Contributor | Publish Date December 17, 2019
Full Story

Research    Patient Care    Press Releases

Long-Acting Contraception has Proven Highly Effective but Restricted in Some Hospitals

Long-acting reversible contraceptives like intrauterine implants have greatly reduced unintended pregnancies and abortions, but government protections allowing religious hospitals to restrict care are limiting access to health care consumers, according to an expert at the University of Colorado Anschutz Medical Campus.


Author David Kelly | Publish Date December 17, 2019
Full Story

Research    Patient Care

Breakthrough Therapy Approved for Cystic Fibrosis Patients

Earlier this fall, the FDA approved a new breakthrough therapy for cystic fibrosis (CF), a genetic disease that leads to lung, digestive, endocrine and nutritional problems. Researchers from Children’s Hospital Colorado and the University of Colorado School of Medicine, were part of a national network that oversaw clinical trials leading to the approval of TRIKAFTA, a highly-effective treatment for people with CF, 12 years of age and older. The trials have taken place in the CCTSI’s pediatric Clinical and Translational Research Center (CTRC) at Children’s Colorado.


Author Guest Contributor | Publish Date December 12, 2019
Full Story

Research    Press Releases

High Doses of Vitamin D for Critically Ill Patients Yield Minimal Benefit

A major study conducted by the National Heart, Lung and Blood Institute’s Prevention and Early Treatment of Acute Lung Injury (PETAL) Network into whether high doses of vitamin D can improve health outcomes for critically ill patients has concluded that such supplements do not reduce mortality or improve other non-fatal outcomes.


Author Guest Contributor | Publish Date December 12, 2019
Full Story

Research    Press Releases

Infant Morbidity Decreases with Incentive-Based Prenatal Tobacco Interventions

Colorado is taking a critical step to protect low-income women during their pregnancy through incentive-based smoking cessation interventions. A new study from the Colorado School of Public Health at the Anschutz Medical Campus shows a significant reduction in infant morbidity due to the program.


Author Julia Milzer | Publish Date December 06, 2019
Full Story

Research

Pouch or Jar? Researchers Compare Nutritional Value of Infant and Toddler Foods

Infant and toddler foods sold in pouches have lower nutritional value than foods sold in jars and other packaging, according to a new study led by researchers from the University of Colorado Anschutz Medical Campus.


Author Guest Contributor | Publish Date December 03, 2019
Full Story

Research    Innovation

Got a Translational Project? SPARK | REACH Accepting Applications

SPARK Colorado, founded in 2018, has been assisting CU Anschutz faculty and researchers in the process of transitioning their discoveries into products that will improve health. The program provides funding, industry mentorship, and a curriculum tailored to the needs of participating members.


Author Guest Contributor | Publish Date December 03, 2019
Full Story

Research    Patient Care    Press Releases

Skin Disease Researchers Win Renewed Grants

National leaders in research to cure debilitating skin diseases based at the Gates Center for Regenerative Medicine on the University of Colorado Anschutz Medical Campus have won a second NIH grant to further investigations of innovative treatments.


Author Guest Contributor | Publish Date November 25, 2019
Full Story

Research    Patient Care    Press Releases

AVITA Medical Teams With Gates Center to Advance Therapeutic Skin Restoration

AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, and scientists at the Gates Center for Regenerative Medicine at the University of Colorado School of Medicine have announced a preclinical research collaboration to establish proof-of-concept and explore further development of a spray-on treatment of genetically modified cells for patients with epidermolysis bullosa (EB), with potential applicability to other genetic skin disorders.


Author Guest Contributor | Publish Date November 25, 2019
Full Story